Suchergebnisse - "Majolino, Ignazio"

PubPharm (16)

1

Leukapheresis cell concentration adjustment required for a successful recovery of HSC after cryopreservation

enthalten in: Cryobiology | 2020

von Mohammed, R. | Ahmad, D. | Khoshnaw, N. | +9

2

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von Trotman, J. | Barrington, S. | Belada, D. | +113

CommentIn: Lancet Oncol. 2018 Nov;19(11):1431-1432. - PMID 30309757

3

Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia : Evaluation on 1,297 patients

enthalten in: American journal of hematology | 2016

von Andriani, A. | Latagliata, R. | Anaclerico, B. | +20

4

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma

enthalten in: Journal of translational medicine | 2012

von Bonanno, G. | Mariotti, A. | Procoli, A. | +13

5

Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment

enthalten in: Blood | 2011

von Morabito, F. | Gentile, M. | Mazzone, C. | +22

6

Hema e-Chart : Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies

enthalten in: Journal of chemotherapy (Florence, Italy) | 2010

von Pagano, L. | Caira, M. | Nosari, A. | +53

7

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis : the superior disease control of R-HDS does not translate into an overall survival advantage

enthalten in: Blood | 2008

von Ladetto, M. | De Marco, F. | Benedetti, F. | +82

8

High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission

enthalten in: Medical oncology (Northwood, London, England) | 2006

von Majolino, I. | Ladetto, M. | Locasciulli, A. | +7

9

Efficacy of imatinib mesylate in a patient with idiopathic hypereosinophilic syndrome and severe heart involvement

enthalten in: Tumori | 2005

von Anghel, G. | De Rosa, L. | Ruscio, C. | +4

10

Primary cardiac lymphoma : report of two cases occurring in immunocompetent subjects

enthalten in: Leukemia & lymphoma | 2004

von Anghel, G. | Zoli, V. | Petti, N. | +4